Revenue scale rose strongly
Consolidated Q2 total income was 3604 ₹ crore (Q2 FY26) versus 4811 ₹ crore (Q2 FY27). Revenue scale rose strongly.
Watch: Compare like-for-like acquisition mix
Home / Research / Endurance Technologies Limited
Revenue scale rose strongly
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
Consolidated Q2 total income was 3604 ₹ crore (Q2 FY26) versus 4811 ₹ crore (Q2 FY27). Revenue scale rose strongly.
Watch: Compare like-for-like acquisition mix
Consolidated Q2 EBITDA was 498 ₹ crore (Q2 FY26) versus 584 ₹ crore (Q2 FY27). EBITDA grew slower than income.
Watch: Monitor material cost
Consolidated Q2 PAT was 227 ₹ crore (Q2 FY26) versus 274 ₹ crore (Q2 FY27). PAT rose but includes multiple below-operating effects.
Watch: Reconcile gain and depreciation
Consolidated EBITDA margin was 13.8 % (Q2 FY26) versus 12.1 % (Q2 FY27). Margin declined by about 170 bps.
Watch: Test recovery in India and Europe
Quarter ended 30 September 2026 · WATCH · consolidated and geographic bases identified. Endurance is an auto-component platform spanning Indian two-wheelers and European automotive systems; the investor needs to distinguish an Indian volume recovery from European margin conditions. Consolidated Q2 FY27 total income increased from approximately ₹3,604 crore to ₹4,811 crore, but EBITDA increased from ₹498 crore to ₹584 crore, suggesting that earnings did not fully match the scale improvement. Reported group PAT grew from ₹227 crore to ₹274 crore. WATCH pending clarity on operating returns on recent acquisitions and consistency of cash generation. [S1][S2]
| Data point | Reference | Current |
|---|---|---|
| Consolidated Q2 total income | 3604 ₹ crore (Q2 FY26) | 4811 ₹ crore (Q2 FY27) |
| Consolidated Q2 EBITDA | 498 ₹ crore (Q2 FY26) | 584 ₹ crore (Q2 FY27) |
| Consolidated Q2 PAT | 227 ₹ crore (Q2 FY26) | 274 ₹ crore (Q2 FY27) |
| Consolidated EBITDA margin | 13.8 % (Q2 FY26) | 12.1 % (Q2 FY27) |
| India standalone income | 2692 ₹ crore (Q2 FY26) | 3761 ₹ crore (Q2 FY27) |
| India standalone EBITDA | 336 ₹ crore (Q2 FY26) | 395 ₹ crore (Q2 FY27) |
| India EBITDA margin | 12.5 % (Q2 FY26) | 10.5 % (Q2 FY27) |
| Europe total income | 908 ₹ crore (Q2 FY26) | 1029 ₹ crore (Q2 FY27) |
Investor takeaways: Consolidated Q2 total income: Revenue scale rose strongly. Consolidated Q2 EBITDA: EBITDA grew slower than income. Consolidated Q2 PAT: PAT rose but includes multiple below-operating effects. Consolidated EBITDA margin: Margin declined by about 170 bps. India standalone income: Indian sales increased amid industry demand. India standalone EBITDA: Domestic EBITDA rose slower than revenues. An Infosys-style graphical briefing precedes the seven analytical chapters and preserves all period/unit definitions.
Endurance is an auto-component platform spanning Indian two-wheelers and European automotive systems; the investor needs to distinguish an Indian volume recovery from European margin conditions. Consolidated Q2 FY27 total income increased from approximately ₹3,604 crore to ₹4,811 crore, but EBITDA increased from ₹498 crore to ₹584 crore, suggesting that earnings did not fully match the scale improvement. Reported group PAT grew from ₹227 crore to ₹274 crore. WATCH pending clarity on operating returns on recent acquisitions and consistency of cash generation. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. Revenue scale rose strongly. Next assess whether management can compare like-for-like acquisition mix. EBITDA grew slower than income. Next assess whether management can monitor material cost. PAT rose but includes multiple below-operating effects. Next assess whether management can reconcile gain and depreciation. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
Standalone India operations recorded Q2 total income around ₹3,761 crore versus ₹2,692 crore in Q2 FY26, while EBITDA increased from ₹336 crore to ₹395 crore. The implied domestic EBITDA margin fell from about 12.5% to about 10.5%, notwithstanding volume gains.
The issuer also reported a ₹40 crore incentive booked during Q2. Management said metal-price inflation restricted margin improvement; this must be distinguished from regular production efficiency. The consolidated Q2 EBITDA margin shown was 12.1% against 13.8% previously. Group reported profit reflects depreciation and acquisition accounting as well as recurring operations. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. PAT rose but includes multiple below-operating effects. Next assess whether management can reconcile gain and depreciation. Margin declined by about 170 bps. Next assess whether management can test recovery in india and europe. Indian sales increased amid industry demand. Next assess whether management can track organic oem volumes. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
The manufacturing base combines aluminum die casting, suspensions, braking systems, transmissions and related automotive components serving vehicle OEMs. Rising Indian two-wheeler demand can improve unit volumes, but OEM price negotiations, aluminum costs and program-level utilization govern returns. The presentation quotes Indian industry H1 FY27 two-wheeler sales of 15.29 million units versus 12.67 million; these are industry units rather than Endurance shipments. European business is exposed to supplier contracts, new vehicle registrations and energy pricing; local growth should not be mislabeled as Indian demand. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. Indian sales increased amid industry demand. Next assess whether management can track organic oem volumes. Domestic EBITDA rose slower than revenues. Next assess whether management can assess metal cost repricing. Standalone India margin compressed. Next assess whether management can separate incentive effects. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
Management described Europe Q2 revenue of about ₹1,029 crore versus ₹908 crore and EBITDA of ₹183 crore versus ₹161 crore. The presentation characterized revenue growth in local euro terms at 5.6% and identified acquisition-accounting gains of ₹36 crore in European PAT partly offset by ₹31 crore of accelerated depreciation from OEM program phase-outs. Analyst and investor questions should therefore separate organic component shipment growth from FX and acquisition effects. Management also discussed ongoing product and customer programs, which are prospective cash flows, not yet guaranteed full-margin sales. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. Standalone India margin compressed. Next assess whether management can separate incentive effects. European revenue rose on a rupee basis. Next assess whether management can differentiate currency and volume. European EBITDA increased. Next assess whether management can audit operating leverage. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
The European factory cost base faces higher electricity and gas prices: an industry/market exhibit in the presentation shows electricity at €182 per MWh versus €110 previously and gas at 67 versus 36 euro cents/cubic metre. These costs can change the payback for production tooling and new customer programs, particularly when contractual price pass-through lags.
Indian Q2 incentive income of ₹40 crore also cannot be assumed quarterly recurring. The accepted source material does not independently provide a full consolidated cash-flow bridge, therefore do not invent Q2 free cash flow, net debt or a specific acquisition IRR. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. European EBITDA increased. Next assess whether management can audit operating leverage. PAT affected by acquisition accounting. Next assess whether management can separate recurring profitability. Industry units improved 20.7%. Next assess whether management can do not treat industry demand as issuer sales. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
An upside scenario needs sustained Indian OEM demand, domestic margin recovery after raw material repricing, improved European production efficiency and sound acquisition execution. A base case assumes revenue growth with stable but lower margins due to material/energy cost pressures. The downside case is persistent commodity inflation, lost European programs, slow ramp of new product lines or integration-related charges that leave reported PAT out of line with core operating earnings. The falsifiers are segment margin trends, original-equipment-program volumes and disclosed cash flow, not a guessed share price. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. Revenue scale rose strongly. Next assess whether management can compare like-for-like acquisition mix. EBITDA grew slower than income. Next assess whether management can monitor material cost. PAT rose but includes multiple below-operating effects. Next assess whether management can reconcile gain and depreciation. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
The action is WATCH. Monitor consolidated income ₹4,811 crore, EBITDA ₹584 crore, PAT ₹274 crore; Indian standalone revenue ₹3,761 crore and domestic EBITDA ₹395 crore; and European income ₹1,029 crore and EBITDA ₹183 crore. Explicitly reconcile the ₹40 crore incentive and the European ₹36 crore acquisition-accounting gain/₹31 crore accelerated depreciation. Prefer program-level return disclosure, working-capital evidence and a defensible stock valuation before upgrading conviction; prolonged margin erosion would weaken the thesis. [S1][S2]
Quarterly evidence and actionable tests
Interpretation. PAT rose but includes multiple below-operating effects. Next assess whether management can reconcile gain and depreciation. Margin declined by about 170 bps. Next assess whether management can test recovery in india and europe. Indian sales increased amid industry demand. Next assess whether management can track organic oem volumes. The relevant comparators must retain their original reporting period and accounting basis; a management expectation or industry figure is not automatically realized group income.
[S1] Endurance Technologies Q2 FY27 earnings-call transcript, call 4 November and NSE filing 12 November 2026. [S2] Endurance Technologies Q2 FY27 investor presentation, BSE filing 3 November 2026.
The issuer presentation and transcript are the sources of financial and operating observations. Company guidance, industry benchmarks and non-recurring accounting items are separately attributed. No unverified price target, dividend, leverage or future project cash-flow model is provided.
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7db536e1-8af1-4922-a687-3191e96c7e61.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.